2nd AFM symposium: Respiratory and ventilatory rehabilitation. Dr Michelle Melicosta 9 2022

preview_player
Показать описание
2nd AFM Virtual Symposium Series for Health Care Providers, Scientists and Families.
Third Session: Acute Presentations and Management for Acute Flaccid Paralysis

Respiratory and ventilatory rehabilitation. Michelle Melicosta MD, MPH, FAAP, Kennedy Krieger Institute & Johns Hopkins University School of Medicine, Baltimore, MD
  1. AFM Working Group- Acute Flaccid Myelitis
Рекомендации по теме
2nd AFM symposium: 0:20:49

2nd AFM symposium: Respiratory and ventilatory rehabilitation. Dr Michelle Melicosta 9 2022

2nd AFM symposium: 0:28:38

2nd AFM symposium: AFM Long-term outcomes and management of secondary consequences. Dr R. Srinivasan

2nd AFM Symposium: 0:28:19

2nd AFM Symposium: ICU/symptomatic management of AFM. Dr Becky Riggs, OHSUSM, Oregon, Portland

2nd AFM Symposium 0:24:04

2nd AFM Symposium Counseling for Caregivers at the Time of AFM Diagnosis Dr S Hopkins

2nd AFM Symposium 0:27:55

2nd AFM Symposium Neuroradiological Manifestations of AFM Dr S Kralik

2nd. AFM symposium: 0:21:58

2nd. AFM symposium: Enteroviruses and AFM. Epidemiological surveillance 2022, A Lopez CDC 9 2022

AFM First Virtual 0:18:57

AFM First Virtual Symposium Part II — Respiratory issues in the acute phase of AFM

Acute Flaccid Myelitis 1:43:21

Acute Flaccid Myelitis (AFM) Symposium - November 1, 2023

2nd AFM Symposium: 0:21:54

2nd AFM Symposium: AFM, Clinical Presentation and Manifestations- when to consider AFM, Dr C Otten

2nd AFM Symposium: 0:23:07

2nd AFM Symposium: Specimen collection and reporting for suspected AFM cases, Adriana Lopez, CDC

2nd AFM Symposium: 0:25:20

2nd AFM Symposium: Viral evolution and epidemiology of EV D68 Dr. Emma Hodcroft, U Bern, 8_2022

2nd AFM Symposium: 0:22:48

2nd AFM Symposium: Initial Evaluation for AFM. Dr Molly Wilson-Murphy, Boston Children's Hosp...

2nd. AFM Symposium: 0:26:39

2nd. AFM Symposium: Mechanisms of Paralysis in AFM A New Hypothesis Dr. William Jackson U. MD 8 2022

2nd. AFM Symposium: 0:26:05

2nd. AFM Symposium: Innate Immune Responses to EV D68 in airways and gut. Dr. Megan C Freeman 8 2022

The Role of 0:57:46

The Role of CDC and Public Health in AFM Surveillance | Part II

2n. AFM Symposium: 0:24:34

2n. AFM Symposium: Monoclonal antibodies in treatment of EV-D68 infection and AFM. Dr. M Vogt, UNC

AFM First Virtual 0:16:57

AFM First Virtual Symposium Part I — What is known about the epidemiology of AFM

AFM First Virtual 0:16:05

AFM First Virtual Symposium Part II — The management of AFM in the ICU

AFM First Virtual 0:38:14

AFM First Virtual Symposium Part IV — Symptom Management in AFM

2nd. AFM Symposium: 0:26:22

2nd. AFM Symposium: New approaches for immunology and viral diagnosis of enteroviruses, Dr B Mainou

AFM First Virtual 0:16:57

AFM First Virtual Symposium Part II — Rehabilitation during the acute phase of AFM

AFM First Virtual 0:17:42

AFM First Virtual Symposium Part II — The neurophysiology of AFM

AFM First Virtual 0:15:39

AFM First Virtual Symposium Part V — The unmet needs in treatment and recovery of AFM patients

2nd. AFM Symposium: 0:29:51

2nd. AFM Symposium: Evaluating virus-like particle vaccines for EV D68. Dr Peter Krug, NIH, 8 2022